Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice

The treatment of patients with advanced breast cancer has developed further in recent years. In addition to therapeutic progress in the established subgroups (hormone receptor and HER2 status), there are now therapies which are geared to individual molecular characteristics, such as PARP inhibitor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Janni, Wolfgang, Schneeweiss, Andreas, Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Hartkopf, Andreas D., Nabieva, Naiba, Taran, Florin-Andrei, Tesch, Hans, Overkamp, Friedrich, Lüftner, Diana, Belleville, Erik, Schütz, Florian, Fasching, Peter A., Fehm, Tanja N., Kolberg, Hans-Christian, Ettl, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414305/
https://www.ncbi.nlm.nih.gov/pubmed/30880825
http://dx.doi.org/10.1055/a-0842-6661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414305/
https://www.ncbi.nlm.nih.gov/pubmed/30880825
http://dx.doi.org/10.1055/a-0842-6661

Ejemplares similares